National Institute of Health Sciences (NIHS) is advancing the regulatory
science research on nanomedicines (the nanotechnology-related drugs). The
objectives of our work at NIHS are the development of an evaluation strategy
of nanomedicines from a standpoint of quality, efficacy and safety.